You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 23, 2024

Actavis Elizabeth Company Profile

✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for ACTAVIS ELIZABETH, and what generic and branded alternatives to ACTAVIS ELIZABETH drugs are available?

ACTAVIS ELIZABETH has one hundred and seventeen approved drugs.

There are five tentative approvals on ACTAVIS ELIZABETH drugs.

Summary for Actavis Elizabeth

US Patents:	0
Tradenames:	77
Ingredients:	77
NDAs:	117
Patent Litigation for Actavis Elizabeth:	See patent lawsuits for Actavis Elizabeth
PTAB Cases with Actavis Elizabeth as petitioner:	See PTAB cases with Actavis Elizabeth as petitioner

Drugs and US Patents for Actavis Elizabeth

+ Get email alerts for changes to this table

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Actavis Elizabeth	ETODOLAC	etodolac	TABLET, EXTENDED RELEASE;ORAL	075696-001	Jul 31, 2000		DISCN	No	No		⤷ Subscribe				⤷ Subscribe
Actavis Elizabeth	LAMOTRIGINE	lamotrigine	TABLET, EXTENDED RELEASE;ORAL	200672-001	Oct 17, 2013	AB	RX	No	No		⤷ Subscribe				⤷ Subscribe
Actavis Elizabeth	DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE	amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate	CAPSULE, EXTENDED RELEASE;ORAL	077302-001	Jun 22, 2012	AB1	RX	No	No		⤷ Subscribe				⤷ Subscribe
Actavis Elizabeth	CARBIDOPA AND LEVODOPA	carbidopa; levodopa	TABLET;ORAL	074260-002	Sep 3, 1993	AB	RX	No	No		⤷ Subscribe				⤷ Subscribe
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.